Healthcare / Medical - Healthcare Information ServicesUpdated 2026-05-10 22:07 UTC

AIM/RENX stock hub

AIM/RENX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/RENXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.9M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/RENX

In the news

Latest news · AIM/RENX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC-1,360.8

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/RENX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

167

Groups with data

Currency

USD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	46
Employees Change	45%
Employees Change Percent	78.95
Enterprise value	GBX 7.6M
Exchange	London Stock Exchange AIM
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Healthcare Information Services
Isin	GB00BYWL4Y04
Last refreshed	2026-05-10
Market cap	GBX 7.9M
Price	GBX 2
Price currency	GBX
Rev Per Employee	53,302.17x
Sector	Healthcare
Sic	7372
Symbol	aim/RENX
Website	https://renalytix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-187.96%
EV Earnings	-0.51x
EV/FCF	-0.78x
EV/Sales	3.09x
FCF yield	-123.73%
P/B ratio	-8.82x
P/S ratio	3.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	45.45%
Gross Profit	GBX 1.1M
Gross Profit Growth	401.67%
Gross Profit Growth Q	1,011.11%
Gross Profit Growth3 Y	18.92%
Net Income	GBX -14.8M
Net Income Growth Quarters	6%
Net Income Growth Years	2%
Pretax Margin	-645.45%
Profit Per Employee	GBX -321,428
Roa5y	-83.98
ROCE	-371.1
ROIC	-1,360.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-75.02%
Cagr3y	-71.88%
Cagr5y	-71.64%
EPS Growth Quarters	6
EPS Growth Years	3
Revenue Growth	40.31x
Revenue Growth Q	36.52x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	-1.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	GBX 7.4M
Cash	GBX 4.6M
Current Assets	GBX 6.2M
Current Liabilities	GBX 4M
Debt	GBX 4.3M
Debt FCF	GBX -0.44
Equity	GBX -891,600
Interest Coverage	-20.88
Liabilities	GBX 8.2M
Long Term Assets	GBX 1.1M
Long Term Liabilities	GBX 4.3M
Net Cash	GBX 297,200
Net Cash By Market Cap	GBX 3.78
Tangible Book Value	GBX -891,600
Tangible Book Value Per Share	GBX -0
WACC	13.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.57
Net Working Capital	GBX -2.2M
Quick ratio	1.39
Working Capital	GBX 2.3M
Working Capital Turnover	GBX -2.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-248.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-75%
200-day SMA	5.7
3Y total return	-97.78%
50-day SMA	2.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.82%
All Time High	1,220
All Time High Change	-99.84%
All Time High Date	2021-05-27
All Time Low	1.6
All Time Low Change	25%
All Time Low Date	2026-04-27
ATR	0.3
Beta	1.82
Beta1y	-0.58
Beta2y	-0.32
Ch YTD	-66.1
High	2
High52	15.5
High52 Date	2025-09-15
High52ch	-87.1%
Low	1.6
Low52	1.6
Low52 Date	2026-05-08
Low52ch	25%
Ma50ch	-16.67%
Price vs 200-day SMA	-64.93%
RSI	13.46
RSI Monthly	33.59
RSI Weekly	18.5
Sharpe ratio	-1.31x
Sortino ratio	-2.06
Total Return	-248.09%
Tr YTD	-66.1
Tr1m	2.56%
Tr1w	11.11%
Tr3m	-65.52%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -12.4M
Operating margin	-506.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	363,947,451%
Net Borrowing	-3,080,758.8
Shares Insiders	5.64%
Shares Institutions	78.22%
Shares Out	437,018,680
Shares Qo Q	0%
Shares Yo Y	248.09%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -12.3M
Average Volume	1,205,629.2x
Bv Per Share	-0
CAPEX	GBX -74,300
Ch1m	2.56
Ch1w	11.11
Ch1y	-75
Ch3m	-65.52
Ch3y	-97.78
Ch5y	-99.82
Ch6m	-72.03
Change	11.11%
Change From Open	14.29
Close	1.8
Days Gap	-2.78
Dollar Volume	185,138
Earnings Date	2026-06-24
EBIT	GBX -12.4M
EPS	GBX -0.04
F Score	3
FCF	GBX -9.7M
FCF EV Yield	-128.59x
FCF Per Share	GBX -0.02
Financing CF	7,132,800
Fiscal Year End	June
Founded	2,018
Income Tax	GBX -1M
Investing CF	-74,300
Is Primary Listing	1
Last Earnings Date	2025-12-17
Last Report Date	2025-12-31
Ma150	5.2
Ma150ch	-61.51%
Ma20	1.87
Ma20ch	6.78%
Net CF	-2,303,300
Next Earnings Date	2026-06-24
Open	1.75
Position In Range	100
Ppne	953,568.2
Price Date	2026-05-08
Relative Volume	0.08x
Revenue	2,451,900x
SBC By Revenue	106.06x
Share Based Comp	2,600,500
Tax By Revenue	-42.42x
Tr6m	-72.03%
Volume	92,569
Z Score	-27.32

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/RENX pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/RENX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/RENX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+78.2%

Share of float held by funds and institutions

Insider ownership

+5.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+248.1%

Negative means the company is buying back shares.

Technical

AIM/RENX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

13.5

Below 30: short-term oversold

Price vs 200-day MA

-64.9%

50/200-day relationship not available

Beta (5Y)

1.82

More volatile than the market

Sharpe ratio

-1.31

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/RENX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/RENX stock rating?

aim/RENX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/RENX analysis?

The full report lives at /stocks/aim/RENX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/RENX?

The latest report frames aim/RENX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/RENX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.